CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).
Clinical trial NCT03848611 · UNKNOWN
Trial details
- NCT number
- NCT03848611
- Sponsor
- AnewPharma
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-02
- Primary completion
- 2021-02-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.